DVA:NYSE
Davita Inc
US$ १८१.७८
arrow_upward
+१.४१%(+२.५३) 1D
US$ १८१.७८
०.००% (०.००)
bedtimeAfter hours
Closed: अक्टोबर १२, १६:००:०७ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DVA...
Open
US$ १७९.६१
High
US$ १८२.२४
Low
US$ १७९.३६
Mkt. cap
११.६० अरब
Avg. vol.
६.५५ लाख
Volume
५.८६ लाख
P/E ratio
१४.८९
52-wk high
US$ २४७.४९
52-wk low
US$ १०१.००
EPS
US$ १२.२१
Beta
०.८०
Shares outstanding
६.३८ करोड
No. of employees
७८ हजार
Open
US$ १७९.६१
High
US$ १८२.२४
Low
US$ १७९.३६
Mkt. cap
११.६० अरब
Avg. vol.
६.५५ लाख
Volume
५.८६ लाख
P/E ratio
१४.८९
52-wk high
US$ २४७.४९
52-wk low
US$ १०१.००
EPS
US$ १२.२१
Beta
०.८०
Shares outstanding
६.३८ करोड
No. of employees
७८ हजार
News stories
From web sources and news partners
News Corp
·
२ घण्टा पहिले
DaVita Inc. stock outperforms competitors on strong trading day
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees७८ हजार
Founded१९९२
Headquartersडेन्वर, कोलोराडो, संयुक्त राज्य अमेरिका
Sector-
Websitedavita.com